April 14, 2021

Oana Caluseriu on a new initiative through WCHRI: The Translational Genomics Hub

Photo supplied by Caluseriu.

Oana Caluseriu is an associate professor in the Department of Medical Genetics, a medical geneticist with experience in both clinical and molecular genetics and a member of the Women and Children’s Health Research Institute.

As the third presenter for WCHRI’s Precision Health Research Seminar Series, Oana sat down with us to discuss translational genomics, how this research is helping families, and a new local initiative through WCHRI: The Translational Genomics Hub.

Can you tell us a little about translational genomics and how it’s improving the health of patients?

Our DNA holds the entire roadmap for the way we grow, develop and function as human beings. Genomics is an approach to testing for genetic disorders that looks at the DNA as a whole. 

If you think about the DNA being represented by the 46 chromosomes, it’s like looking at a library with 46 books. We can go through the library, count the books and see if all of the chapters are there. This is what we have done since the 1950s with the “karyotype” test, which allows us to make sure all 46 books are there. In the last few years, we have started to perform a test called a “microarray”, which allows us to check for the correct number of pages in each book. We can now zoom in on the pages of the books and sequence or read the paragraphs of DNA text, represented by each of the 20,000 genes, and look for “spelling errors”. 

DNA changes will be reflected in the way a patient appears in the clinic, sometimes having changes at different levels at the same time. The same patient may have the wrong number of pages in one of the 46 books together with a spelling error in a paragraph. This will compound the features that we will see in a patient clinically, making the diagnosis all the more complicated. We can look at groups of genes related to a certain problem (such as congenital heart defects) or we can read the text of all of the genes in the DNA at once (whole-exome sequencing). 

Translational genomics means that if we find a significant change at some level in the DNA of a patient, we can take that information back to the patient and use it for their medical care and that of their family. The key is to be able to find a change that we can interpret, enabling improved treatments.

How is this important for the health of women and children?

I work in pediatric genetics and prenatal diagnosis. One side of my work is to diagnose pediatric patients who are suspected to have a genetic disorder. If we’re able to use genomics to identify a mutation in a gene that is linked to that child’s disorder, we understand that person better—how to better care for the patient, anticipate problems that may happen and sometimes introduce specific treatments. We can also counsel the family about the risk of the same disorder happening again in future pregnancies and how we can test the fetus in pregnancy (if the couple is interested) to help them make decisions that best fit the reality of their life. Our findings can be useful by other family members to find out if there is a risk for that particular genetic disorder in themselves or their children. When we look at families, we do not separate children and their adult parents or relatives— we see them as a unit related by their shared DNA. 

How did you get involved in this research?

In 2009, I was at a conference in Philadelphia where a geneticist, Michael Bamshad, announced that he had discovered the cause of a rare disorder using a new technology called “whole-exome sequencing”. Whole-exome sequencing reads the text of all the 20,000 genes in one go. Traditionally, we were testing one gene at a time and for many disorders, we did not know what the culprit gene was. There was sighing and gasping in the room after Michael presented… we understood that this was going to be a game-changer! 

Very soon after, initiatives in Canada to develop nationwide projects sprang up, led by Kym Boycott in Ottawa, a colleague geneticist who had trained in genetics in Calgary where I was a resident at the time. That was the moment I decided to continue my training with a fellowship to learn about this new and revolutionary technology—a skill I brought to Edmonton when I joined the University of Alberta in 2012.

What is the Translational Genomics Hub?

The Translational Genomics Hub (TGH) is a new initiative supported by WCHRI. The idea is that the hub will be a facilitator to connect the clinical world with the research world. We want clinicians who have patients whose disease is likely due to a genomics cause to be able to ask questions of researchers who have expertise with that gene or pathway in a lab.

In the TGH, clinicians will be able to bring forward potentially relevant changes they find in a patient’s DNA through testing, but which are missing biological evidence to support the disease-causing effect. Clinicians can also bring candidate genes that are suspected to cause a new genetic disorder. 

The TGH will connect clinicians with researchers who can help find essential biological evidence to confirm the role of the variant or candidate gene. This evidence is fundamental to have an impact on making a diagnosis and to start thinking of new treatments. The TGH is meant to be a living example of how the translation of DNA findings is applied to patient care. 

This is a way to envision precision health from a genetic perspective! 

How can other researchers get involved?

We want to make TGH known to everyone in the medical community in Edmonton. We want to facilitate the connection between clinicians and researchers in a meaningful manner and on a wider scale, and to utilize resources in a more timely and efficient way in order to answer the needs of the patients in today’s modern healthcare system. As rare genetic diseases are much more commonly observed in pediatric practice, we are targeting pediatricians and pediatric sub-specialists at first.

We are still in the building phase but we will be talking about TGH and how to get involved soon, so stay tuned!

Oana Caluseriu spoke at WCHRI’s Precision Health Research Seminar about genomics and a new local initiative through WCHRI: The Translational Genomics Hub. Watch the Zoom replay now!